Clinical trials with oral oxamniquine (UK 4271) for the treatment of mansonian schistosomiasis.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000871:Anthelmintics / Q000008:administration & dosage*; D002648:Child; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D009574:Nitro Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D011437:Propylamines / Q000008:administration & dosage / Q000627:therapeutic use; D011804:Quinolines / Q000008:administration & dosage* / Q000627:therapeutic use; D012552:Schistosomiasis / Q000188:drug therapy*; D012556:Schistosomicides / Q000008:administration & dosage / Q000627:therapeutic use
D000871:Anthelmintics; D009574:Nitro Compounds; D011437:Propylamines; D011804:Quinolines; D012556:Schistosomicides